Generic and biosimilar drugs have entered the MS treatment scene. Learn the facts to help you prepare for treatment decisions with your MS provider. In this webinar we’ll address the basics of generics vs. biosimilars such as what they are, how they’re developed and approved by the FDA, or whether they’re as effective as other treatments on the market. In addition, we’ll address concerns about having to switch from the DMT you’re on and whether insurance will pay for these new options.

This program is possible thanks to the generous support of the following sponsor:

Learn more about Sandoz